Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001445064-15-000151
Filing Date
2015-12-02
Accepted
2015-12-02 16:42:34
Documents
1
Period of Report
2015-12-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3227
  Complete submission text file 0001445064-15-000151.txt   4513
Mailing Address DAMASTOWN MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 675 MCDONNELL BLVD. HAZELWOOD MO 63042
Business Address
Harbaugh Matthew K (Reporting) CIK: 0001578368 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 151265196